New Tools to Decipher the Role of lncRNAs and Their Protein Interactomes in Hematopoiesis
破译lncRNA及其蛋白质相互作用组在造血作用中作用的新工具
基本信息
- 批准号:10368117
- 负责人:
- 金额:$ 44.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AblationAdultAnemiaBinding ProteinsBiologicalBiological ProcessBlood CellsCRISPR/Cas technologyCell LineCell MaintenanceCell physiologyCellsChildhoodChromatinComplexComputer softwareDNADataDevelopmentDistantDysmyelopoietic SyndromesElementsEnhancersErythroblastsErythrocytesErythroidErythroid CellsErythroid Progenitor CellsEvaluationGATA1 geneGene ExpressionGene Expression RegulationGenerationsGenesGeneticGenetic TranscriptionGenomicsGleanHematopoiesisHematopoieticHematopoietic SystemHistonesHumanImmunologic Deficiency SyndromesKnowledgeLocationMalignant - descriptorMalignant lymphoid neoplasmMass Spectrum AnalysisMeasurementMediatingMolecularMusMutant Strains MiceMyelogenousOligonucleotidesPathologyPerformanceProtein AnalysisProtein DatabasesProteinsProteomicsProtocols documentationRNARNA analysisRegulator GenesResearchRoleSamplingSiteSoftware ToolsSystemTestingTimeTranscriptional RegulationUntranslated RNAValidationcell growthcell typecohortcomplement systemdesigndifferential expressionexperimental studyhistone modificationknock-downleukemia/lymphomamutantnovelopen sourceprotein complexprotein expressionproteogenomicssmall hairpin RNAsoftware developmenttechnology developmenttooltranscriptome
项目摘要
Project Summary/Abstract
Bioanalytical tools to study long noncoding RNAs (lncRNAs) and their protein interactors are desperately
needed. lncRNAs are critical elements in the transcriptional regulation of gene expression. They have been
shown to function through several different mechanisms. They may serve directly as gene-regulatory factors,
produced by transcription at the genomic site where they act. Alternatively, lncRNAs interact with proteins to
control gene expression. For example, lncRNAs can act as a “molecular sink” for proteins that interact with
DNA or RNA; in this case, binding of the protein to the lncRNA competes with its interaction with its primary
target. lncRNAs can also guide proteins to their DNA targets to either repress or activate transcription. They
can act not only in cis, or near their site of transcription, but also in trans, at multiple genomic sites. Finally,
lncRNAs can act as platforms upon which molecules can convene to perform a function as a team at a specific
location and time (e.g. histone modification complexes). Each of these mechanisms requires the interaction of
lncRNAs with a diverse protein cohort. Knowledge of the proteins bound to specific lncRNAs is thus essential
information needed to understand mechanisms by which lncRNAs control gene expression. Unraveling this
tremendous diversity of interactions demands tools capable of rapid identification and quantification of lncRNA-
associated proteins. Despite the great importance of lncRNAs and the proteins that interact with them, there
are significant limitations in the tools available to study them. We propose to develop and validate a suite of
powerful new tools for the discovery, identification, and quantification of lncRNAs and for the comprehensive
proteomic analysis of their protein interactomes.
It is known that lncRNAs direct gene expression to modulate cell fate in the hematopoietic system, enabling
diversification of gene programming during development. Disrupted lncRNA function can also contribute to
malignant transformation in specific myeloid and lymphoid cancers. GATA factor-regulated lncRNAs,
discovered in powerful genetic systems (wild type and Gata2 enhancer-mutant mice, GATA-1 genetic
complementation system and GATA factor knockdowns in primary human erythroid precursor cells), control
human erythroid precursor cell function and erythrocyte development. In initial profiling studies, we have
identified 74 GATA factor-regulated lncRNAs. The performance of the new tools developed here will be
thoroughly tested on a subset of these 74 lncRNAs to discover GATA factor-dependent regulatory circuits and
networks that control hematopoiesis.
The proposed research will drive state-of-the-art lncRNA identification and proteomic analysis of the lncRNA
interactome, applied to one of the most important regulatory networks in hematopoiesis. We will bring a new
and unprecedented level of visibility to the definition of the GATA factor-relevant lncRNA interactome, while
developing powerful open-source software tools and detailed experimental protocols.
项目摘要/摘要
研究长不编码RNA(LNCRNA)及其蛋白质相互作用的生物分析工具拼命
需要。 LNCRNA是基因表达转录调控中的关键元素。他们曾经
显示通过几种不同的机制发挥作用。它们可以直接用作基因调节因素,
通过转录在其作用的基因组部位产生。或者,LNCRNA与蛋白质相互作用
控制基因表达。例如,lncRNA可以充当与与
DNA或RNA;在这种情况下,蛋白质与lncRNA的结合与其主要的相互作用竞争
目标。 LNCRNA还可以引导蛋白质到其DNA靶标,以抑制或激活转录。他们
不仅可以在顺式或在其转录部位附近起作用,而且可以在多个基因组部位作用。最后,
lncrnas可以充当平台,分子可以方便地在特定方面执行团队的功能
位置和时间(例如Hisstone修饰复合体)。这些机制中的每一个都需要相互作用
LNCRNA具有潜水蛋白队列的LNCRNA。因此,对与特定lncRNA结合的蛋白质的了解至关重要
了解LNCRNA控制基因表达的机制所需的信息。解开这个
相互作用的巨大多样性需要能够快速识别和定量lncrna-的工具
相关蛋白质。尽管LNCRNA和与它们相互作用的蛋白质非常重要,但
是可用于研究它们的工具的重大局限性。我们建议开发和验证一套
强大的新工具,用于发现,识别和量化LNCRNA和综合
其蛋白质相互作用的蛋白质组学分析。
众所周知,lncRNA直接基因表达调节造血系统中的细胞命运,使得能够
开发过程中基因编程的多样化。破坏的lncRNA功能也会有助于
特定髓样和淋巴癌的恶性转化。 GATA因子调节的LNCRNA,
在强大的遗传系统(野生型和GATA2增强子突变小鼠,GATA-1遗传中发现)发现
原代人红细胞前体细胞中的互补系统和GATA因子敲低)对照
人红细胞前体细胞功能和红细胞发育。在最初的分析研究中,我们有
鉴定出74个GATA因子调节的LNCRNA。这里开发的新工具的性能将是
在这74个LNCRNA的子集上进行了彻底的测试,以发现GATA因子依赖性调节电路和
控制造血的网络。
拟议的研究将推动LNCRNA的最新lncRNA鉴定和蛋白质组学分析
Interactome,应用于造血中最重要的调节网络之一。我们将带一个新的
以及对与GATA因子相关的lncRNA相互作用的定义的前所未有的可见性水平,而
开发强大的开源软件工具和详细的实验协议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emery H Bresnick其他文献
Emery H Bresnick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emery H Bresnick', 18)}}的其他基金
New Tools to Decipher the Role of lncRNAs and Their Protein Interactomes in Hematopoiesis
破译lncRNA及其蛋白质相互作用组在造血作用中作用的新工具
- 批准号:
10570964 - 财政年份:2020
- 资助金额:
$ 44.43万 - 项目类别:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
通过 ENCODE-deri 注释重复基因组区域的统计方法
- 批准号:
9060461 - 财政年份:2012
- 资助金额:
$ 44.43万 - 项目类别:
Novel Determinants of Terminal Erythroid Maturation
红细胞终末成熟的新决定因素
- 批准号:
8550827 - 财政年份:2012
- 资助金额:
$ 44.43万 - 项目类别:
Novel Determinants of Terminal Erythroid Maturation
红细胞终末成熟的新决定因素
- 批准号:
8681511 - 财政年份:2012
- 资助金额:
$ 44.43万 - 项目类别:
Novel Determinants of Terminal Erythroid Maturation
红细胞终末成熟的新决定因素
- 批准号:
8875745 - 财政年份:2012
- 资助金额:
$ 44.43万 - 项目类别:
Novel Determinants of Terminal Erythroid Maturation
红细胞终末成熟的新决定因素
- 批准号:
8417051 - 财政年份:2012
- 资助金额:
$ 44.43万 - 项目类别:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
通过 ENCODE-deri 注释重复基因组区域的统计方法
- 批准号:
8687990 - 财政年份:2012
- 资助金额:
$ 44.43万 - 项目类别:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
通过 ENCODE-deri 注释重复基因组区域的统计方法
- 批准号:
8402305 - 财政年份:2012
- 资助金额:
$ 44.43万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Therapeutic Editing of Rod Glycolysis Rescues Retinal Degeneration
杆状糖酵解的治疗性编辑可挽救视网膜变性
- 批准号:
10607717 - 财政年份:2023
- 资助金额:
$ 44.43万 - 项目类别:
ULK-mediated autophagy of α-globin in ß-thalassemia
α-地中海贫血中 ULK 介导的 α-珠蛋白自噬
- 批准号:
10649565 - 财政年份:2022
- 资助金额:
$ 44.43万 - 项目类别:
Enhancing cone survival in retinitis pigmentosa through cell-specific therapeutic CRISPR editing of a roxadustat target
通过 roxadustat 靶标的细胞特异性治疗性 CRISPR 编辑来增强色素性视网膜炎中视锥细胞的存活
- 批准号:
10624450 - 财政年份:2022
- 资助金额:
$ 44.43万 - 项目类别:
Enhancing cone survival in retinitis pigmentosa through cell-specific therapeutic CRISPR editing of a roxadustat target
通过 roxadustat 靶标的细胞特异性治疗性 CRISPR 编辑来增强色素性视网膜炎中视锥细胞的存活
- 批准号:
10421156 - 财政年份:2022
- 资助金额:
$ 44.43万 - 项目类别:
Repurposing of KCa3.1 Inhibitor Senicapoc for Stroke: A Pre-clinical Study
KCa3.1 抑制剂 Senicapoc 治疗中风的再利用:临床前研究
- 批准号:
10290659 - 财政年份:2021
- 资助金额:
$ 44.43万 - 项目类别: